Pharmaceutical market in the Republic of Croatia

Most European health systems are currently undergoing reforms.According to the World Health Organization, the aim of the healthsystem reforms are health gains, and one of the issues brought tothe foreground with respect to this is cost-containment. Availableindicators show that there is an irrationa...

Full description

Bibliographic Details
Main Authors: Jerko Glavaš, Maja Lamza – Maronić
Format: Article
Language:English
Published: Medical Association of Zenica-Doboj Canton 2008-02-01
Series:Medicinski Glasnik
Subjects:
Online Access:http://www.ljkzedo.com.ba/medglasnik/vol51/M8_8.pdf
_version_ 1819094028134645760
author Jerko Glavaš
Maja Lamza – Maronić
author_facet Jerko Glavaš
Maja Lamza – Maronić
author_sort Jerko Glavaš
collection DOAJ
description Most European health systems are currently undergoing reforms.According to the World Health Organization, the aim of the healthsystem reforms are health gains, and one of the issues brought tothe foreground with respect to this is cost-containment. Availableindicators show that there is an irrational over-consumption ofmedicines. The paper aims to make a contribution towards rationalizingthe use of medicines through the application of a morerational pharmacotherapy, i.e. using the most recent achievementsof pharmacoeconomics.Rational pharmacotherapy implies using the right medicine in theright dosage, over a necessary time period, and at the lowest costfor both an individual and the community. The decrease of excessiveconsumption would result in a better operation of the medicinemarket, as the Croatian Health Insurance Institute would be able tomake more regular and more timely payments to pharmaceuticalwholesalers, which would improve business results of pharmaceuticalwholesalers, pharmacies, and factories (Belupo, Pliva-Barr).It is a well-known fact that the demand for drugs (and othergoods) is always higher than the actual payment ability. In mostcountries in the world the expenses for drugs grow faster thanGDP and make up 10-20% of total health care costs, i.e. 1-2%of GDP.The analyses conducted in the developed countries indicate thatthe increase in drug expenses is influenced mostly by the changes ofthe population’s demographic structure (aging of the population),chronic non-infectious diseases, and the dynamics of continuousintroduction of new and increasingly more expensive drugs.
first_indexed 2024-12-21T23:20:53Z
format Article
id doaj.art-a97e2ca653674105928f7f61ef1025f1
institution Directory Open Access Journal
issn 1840-0132
1840-2445
language English
last_indexed 2024-12-21T23:20:53Z
publishDate 2008-02-01
publisher Medical Association of Zenica-Doboj Canton
record_format Article
series Medicinski Glasnik
spelling doaj.art-a97e2ca653674105928f7f61ef1025f12022-12-21T18:46:47ZengMedical Association of Zenica-Doboj CantonMedicinski Glasnik1840-01321840-24452008-02-01514448Pharmaceutical market in the Republic of CroatiaJerko GlavašMaja Lamza – MaronićMost European health systems are currently undergoing reforms.According to the World Health Organization, the aim of the healthsystem reforms are health gains, and one of the issues brought tothe foreground with respect to this is cost-containment. Availableindicators show that there is an irrational over-consumption ofmedicines. The paper aims to make a contribution towards rationalizingthe use of medicines through the application of a morerational pharmacotherapy, i.e. using the most recent achievementsof pharmacoeconomics.Rational pharmacotherapy implies using the right medicine in theright dosage, over a necessary time period, and at the lowest costfor both an individual and the community. The decrease of excessiveconsumption would result in a better operation of the medicinemarket, as the Croatian Health Insurance Institute would be able tomake more regular and more timely payments to pharmaceuticalwholesalers, which would improve business results of pharmaceuticalwholesalers, pharmacies, and factories (Belupo, Pliva-Barr).It is a well-known fact that the demand for drugs (and othergoods) is always higher than the actual payment ability. In mostcountries in the world the expenses for drugs grow faster thanGDP and make up 10-20% of total health care costs, i.e. 1-2%of GDP.The analyses conducted in the developed countries indicate thatthe increase in drug expenses is influenced mostly by the changes ofthe population’s demographic structure (aging of the population),chronic non-infectious diseases, and the dynamics of continuousintroduction of new and increasingly more expensive drugs.http://www.ljkzedo.com.ba/medglasnik/vol51/M8_8.pdfPharmaceutical marketRepublic of Croatiaeconomics
spellingShingle Jerko Glavaš
Maja Lamza – Maronić
Pharmaceutical market in the Republic of Croatia
Medicinski Glasnik
Pharmaceutical market
Republic of Croatia
economics
title Pharmaceutical market in the Republic of Croatia
title_full Pharmaceutical market in the Republic of Croatia
title_fullStr Pharmaceutical market in the Republic of Croatia
title_full_unstemmed Pharmaceutical market in the Republic of Croatia
title_short Pharmaceutical market in the Republic of Croatia
title_sort pharmaceutical market in the republic of croatia
topic Pharmaceutical market
Republic of Croatia
economics
url http://www.ljkzedo.com.ba/medglasnik/vol51/M8_8.pdf
work_keys_str_mv AT jerkoglavas pharmaceuticalmarketintherepublicofcroatia
AT majalamzamaronic pharmaceuticalmarketintherepublicofcroatia